- Formosa Plastics reported sales of NT$16.14 billion for August 2024.
- This is a decrease of 7.8% compared to August 2023.
- Sales have dropped by NT$1.36 billion from last year’s NT$17.50 billion.
- There are 2 buy recommendations for Formosa Plastics‘ stock.
- There are also 10 hold recommendations.
- Additionally, there are 3 sell recommendations.
- These sales figures are based on Formosa Plastics‘ original disclosures.
A look at Formosa Plastics Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Formosa Plastics Corporation, a leading manufacturer of plastics and chemical fiber products, has received a promising overall outlook according to Smartkarma Smart Scores. With a top score in the Value category, Formosa Plastics is deemed to be offering strong value potential for investors. Additionally, the company’s respectable scores in Dividend and Resilience suggest a stable income stream and a solid ability to weather challenging market conditions. However, lower scores in Growth and Momentum indicate slower anticipated growth and momentum within the company.
Formosa Plastics‘ core business of producing PVC resins, high density polyethylene, and other key products positions it as a significant player in the plastics and chemical fiber industry. This diversified product portfolio reflects the company’s strong market presence and expertise in meeting various industry needs. While investors may find value and stability in Formosa Plastics, they should consider the lower growth and momentum scores as factors to weigh in their long-term investment decisions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
